Baker McKenzie
Contact us
Talent
Español
Echecopar Echecopar
  • Insight
  • News
  • Expertise
    For Industries
    • Consumer Goods & Retail
    • Education
    • Energy, Mining & Infrastructure - EMI
    • Financial Institutions
    • Healthcare & Life Sciences
    • Industrials, Manufacturing & Transportation
    • Private Equity
    • Real Estate
    • Sports Law
    • Technology, Media & Telecommunications
    Por Especializaciones
    • Agribusiness
    • Antitrust & Competition
    • Banking Law
    • Capital Markets
    • Civil Law
    • Competitive Bidding
    • Compliance
    • Concessions and PPP's
    • Constitutional Law
    • Construction
    • Corporate
    • Corporate Governance
    • Corporate Reorganization
    • Dispute Resolution
    • Domestic and International Arbitrations
    • Employment & Compensation
    • Environmental
    • Financing
    • Fintech
    • Fishing
    • Immigration & Mobility
    • Insurance & Reinsurance
    • Intellectual Property
    • International Commercial & Trade
    • Litigation
    • Mergers and Acquisitions
    • Mining
    • Oil and Gas
    • Pension Funds
    • Pharmaceuticals
    • Power
    • Private Equity
    • Project Finance
    • Projects in Assets
    • Public Law
    • Real Estate
    • Restructuring & Insolvency
    • Tax
    • Transfer Pricing
    • Transportation Infrastructure
    • Wealth Management
    • Works for Taxes
  • People
  • About
    One of the most prestigious firms in Peru
    Over 70 years of continuous professional practice
    • About the Firm
    • Out History
    • Founder's Biography
    • Association with Baker McKenzie
    • Corporate Social Responsibility
    • Diversity & Inclusion
    • Pro Bono
    • Acknowledgments
Echecopar
Cerrar
   
  •     Expertise
  •     Practices
  •     Pharmaceuticals

Pharmaceuticals

Client Alert | May 21, 2024

Peru: Law guaranteeing access to and use of generic drugs has been published

See more    

    Description

    Healthcare and life sciences are among the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often differ from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

    As one of the first law firms to advise pharmaceutical companies, our healthcare and life sciences lawyers understand the challenges industry players face and what it takes to overcome them. As trusted advisors to the world's largest pharmaceutical, biotech, medical device and healthcare services companies, we have a multidisciplinary team who applies their expertise to help clients overcome legal and business challenges.

    Completing more cross-border transactions than any other law firm, our global healthcare and life sciences team not only works across borders, but across practice areas to coordinate the worldwide protection of healthcare patents and brands, develop global transfer pricing and tax planning strategies, and represent clients in product liability cases and complex disputes. We also advise on the legal and regulatory aspects of healthcare and life sciences advertising and marketing, clinical trials, competition and trade, commercial agreements, data privacy, employment issues, and market entry.

    Key Contacts

    Rosmery Rivera
    Senior Associate
       Lima
       +51 (1) 618 8403
       vCard
         rosmery.rivera@bakermckenzie.com

    Publications

    Client Alert | May 31, 2024
    Peru: Entry into force of the Regulations on hazardous substances for domestic, industrial and/or public health use
    Pharmaceuticals | Environmental
    Client Alert | May 21, 2024
    Peru: Law guaranteeing access to and use of generic drugs has been published
    Pharmaceuticals
    Client Alert | May 17, 2023
    Peru: Regulation for the registration and re-registration of certain biological products are approved
    Healthcare & Life Sciences
    Client Alert | May 12, 2023
    Peru: Modification of the law on rare or orphan diseases
    Pharmaceuticals
    Client Alert | July 15, 2022
    Regulation for the importation or procurement of vaccines and medicines against SARS-CoV-2 Coronavirus is approved
    Client Alert | June 3, 2022
    New regulatory facilitation measures for pharmaceutical products
    Sanitary Regulation
    Client Alert | January 12, 2022
    Peru: Facilitation of trade in sanitary products in the Andean Community
    Client Alert | June 21, 2021
    Law promoting the acquisition of vaccines by the private sector and other sectors
    Client Alert | November 4, 2019
    Access to Medication, Biological Products and Medical Devices
    Spanish content

    News

    Announcements | April 12, 2022
    The ban on the use of Octagon stickers on imported food constitutes a nontariff trade barrier

    Acknowledgments

    • Chambers & Partners
      Practices201820192020
      PharmaceuticalsNRBand 2Band 2

      Testimonials

      Band 2: Chambers and Partners — 2020

      "They are competent, have ample knowledge of Peruvian and international regulations and are at the forefront of regulatory initiatives."

Contact us
Terms & Conditions
Privacy Statement
Email Disclaimer
Media Contacts
Agenda Legal
Talent
Versión Español
Copyright © 2025 Estudio Echecopar